Our customers depend upon the end-to-end services we provide throughout the lifecycle of their products, from research and development, to product manufacturing and sterilization, as well as ongoing quality control.  Our customers include 40 of the world’s top 50 medical device companies, eight of the top 10 global pharmaceutical companies and many of the largest companies in the food processing industry, all of whom rely on our expertise to ensure that the products they take to market are safe and effective.

Medical Devices

  • Global medical device R&D spend for top 20 companies is expected to grow at a 4% CAGR and reach ~$24bn by 20244
  • More than 20bn devices sold in the United States every year are sterilized with EO, accounting for ~50% of devices that require sterilization6


  • Worldwide pharmaceutical R&D spend forecasted to grow steadily at a ~3% CAGR, reaching $233bn by 20265
  • Increasing regulatory and risk management demands in the pharmaceutical space


  • 1 in 6 Americans get sick from contaminated foods or beverages every year7
  • 3,000 Americans die annually from foodborne illnesses7
  • Foodborne illnesses cost ~$16bn each year8

1 Data published by the United Nations in 2019; 2 Estimates by the Centers for Medicare & Medicaid Services in 2020; 3 Based on revenue; 4 EvaluatePharma® July 2020, Evaluate Ltd; 5 2019-2026 CAGR; 6 Food and Drug Administration, 2019; 7 Center for Disease Control and Prevention; 8 US Department of Agriculture